{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to MedStarHealth.org
MedStar Health
  • Sign In
  • Conferences
  • RSS
  • Online Courses
  • Learning from Teaching
  • Podcasts
  • Contact Us
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
MedStar associates, you will log in to CloudCME with your SiTEL Learning Management System (SITELMS) account on the next screen.

If you are not a MedStar associate, you can log in or create an account on the next screen.

For login assistance, contact the SiTEL Help Center at 1-855-745-1861 (Mon-Fri 8 AM to 5 PM) or at [email protected]
I am a MedStar Associate (login via SiTEL)
I am Not a MedStar Associate
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • AAS
  • BSN
  • BSND
  • BSRT
  • CCT
  • CNM
  • CRNP
  • CRNP, RN
  • CVT
  • DNP
  • DO
  • DPM
  • DPM, MS
  • DPM. MPH
  • DPT
  • JD
  • LCSW-C
  • LMSW
  • LPN
  • MA
  • MBBS, DTMH
  • MD
  • MD, FACC
  • MD, FACS
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, MSc, MBA
  • MD, PhD
  • MD, PhD, MS
  • MGC, CGC
  • MPH
  • MS
  • MS, MPH, CGC
  • MSN
  • MSOTR/L, CLT
  • MSPH
  • MSW
  • None
  • NP
  • Other
  • OTR
  • PA
  • PharmD
  • PhD
  • PT
  • PT, DPT
  • RCES
  • RCIS
  • RD
  • RDN
  • RN
  • RN, BSN
  • RN, BSN, CCRN, CWON
  • RT

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

D.C. Lung Cancer Conference 2022


D.C. Lung Cancer Conference 2022 Banner

  • Overview
  • Faculty
  • Schedule
  • Brochure
  • Venue
  • Exhibitors
  • Support
Add to Calendar D.C. Lung Cancer Conference 2022 10/29/2022 8:00:00 AM 10/29/2022 5:05:00 PM America/New_York For More Details: https://medstar.cloud-cme.com/course/courseoverview?P=0&EID=18667 Pooks Hill Marriott false MM/DD/YYYY


Date & Location
Saturday, October 29, 2022, 8:00 AM - 5:05 PM, Pooks Hill Marriott, Bethesda, MD

Target Audience
Specialties - Internal Medicine, Medical Oncology, Oncology, Pathology, Pulmonology, Radiation Oncology, Radiology, Surgery
Professions - Non-Physician, Nurse, Pharmacist, Physician, Student

Overview

Registration is closed until  8:00 AM on October 29, 2022 onsite at Pooks Hill Marriott, Bethesda, MD.

 

This one-day symposium will provide an update on recent clinical advances in lung cancer. The field is evolving very rapidly and over the past year, there have been major shifts in our understanding of this highly lethal disease. We have seen high impact advances in all aspects of lung cancer management: from detection, to diagnosis to treatment. This symposium will emphasize current best practices for busy clinicians who care for patients with lung cancer, across disciplines. High impact didactic talks will be delivered by national thought leaders and well-respected faculty in each field. There will be updates on CT screening, proper use of liquid biopsy, interpretation of molecular testing results and review of smoking cessation techniques. A section will be dedicated to optimizing multidisciplinary care for early stage and locally advanced lung cancer to include discussions on proton beam radiation, minimally invasive surgery and immunotherapy. Sessions with important updates on targeted therapy and immunotherapy will feature recognized experts in the field and there will be a debate over neoadjuvant vs adjuvant immunotherapy for resectable NSCLC. Attendees will have the opportunity to interact with faculty in frequent Q&A sessions and through a case-based format following each session with access to presentation materials for later review.

 

Endorsed by:



Objectives
After completing this activity, the participant will be able to:

  1. Identify the benefit of CT screening for lung cancer.
  2. Discuss the current application of liquid biopsy (or ctDNA analysis).
  3. Explain the approved adjuvant and neoadjuvant treatment options for resectable, driver negative non-small cell lung cancer.
  4. Discuss standard targeted agents in use for patients with ALK-positive non-small cell lung cancer.
  5. Describe the benefit of immunotherapy in the treatment of small cell lung cancer.
  6. Explain the approved use of targeted therapy for KRAS-mutant non-small cell lung cancer.
  7. Debate the use of targeted therapy for patients with resected EGFR mutant non-small cell lung cancer.
  8. Explain the toxicity associated with targeted therapy given after immunotherapy in EGFR mutant non-small cell lung cancer.
  9. Discuss management of immune-mediated toxicities.
  10. Identify nursing strategies for early detection of immune-mediated toxicities.
  11. Recognize unique toxicities associated with targeted agents used in NSCLC.
  12. Recognize common immune related adverse events and factors that increase patient risk.
  13. Discuss standard targeted agents in use for patients with driver-positive non-small cell lung cancer.
  14. Explain the toxicity associated with targeted therapy given after immunotherapy in EGFR mutant non-small cell lung cancer.
  15. Identify the pharmacologic management of immune-mediated adverse events based on current guidelines and evidence.
  16. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with lung cancer.
  17. Integrate a team-based approach in the care of patients with lung cancer.

Registration
  • Physician $175
  • IASLC Member  $140
  • Resident/Fellow $100
  • Physician Assistant $100
  • Nurse Practitioner $100
  • Nurse $100
  • Pharmacist $100
  • Allied Health Professional $100
  • Industry Professional $250

 


Accreditation

 In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation Statement

This activity was planned by and for the healthcare team and learners will receive 6.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

 

Physicians: MedStar Health designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 6.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists: This activity is approved for 6.25 contact hours. This learning activity is knowledge-based. The Universal Activity Number for this program is UAN# JA4008151-0000-22-014-L05-P


Credits
AMA PRA Category 1 Creditsâ„¢ Physician (6.25 hours), Nurse - ANCC (6.25 hours), Non-Physician Member of the Healthcare Team (6.25 hours), Pharmacist - ACPE (6.25 hours), IPCE (6.25 hours)
The registration form for this activity is currently unavailable.

Bethesda Marriott

5151 Pooks Hill Road

Bethesda, MD 20814

Use the below link to book your hotel room with the Lung Cancer Conference discount at $109 per night:

Click here to book your hotel room for DC Lung Cancer Conference 2022

The last day to book your hotel room is Thursday, October 13th.




Mitigation of Relevant Financial Relationships


MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

 
Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.



Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Faculty Photos
Stephen V. Liu, MD
Director, Thoracic Medical Oncology, Director, Phase I Developmental Therapeutics, Associate Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC
Course Director, Faculty
Advisor-Amgen|Advisor-AstraZeneca AstraZeneca|Advisor-Bayer Corporation|Advisor-Beigene|Advisor-Blueprint Medicines|Advisor-BMS|Advisor-Boehringer Ingelheim (Relationship has ended)|Advisor-Catalyst (Relationship has ended)|Advisor-Daiichi Sankyo, Inc.|Advisor-Eisai|Advisor-Elevation Oncology|Advisor-Elevation|Advisor-Genentech, Inc.|Advisor-Gilead Sciences, Inc.|Advisor-Guardant Health|Advisor-Janssen|Advisor-Jazz Pharmaceuticals|Advisor-Lilly Oncology|Consulting Fee-Merck|Advisor-Novartis Pharmaceuticals|Advisor-Regeneron|Advisor-Sanofi|Advisor-Takeda|Advisor-Turning Point Therapeutics|Grant or research support-Alkermes|Grant or research support-Blueprint Medicines|Grant or research support-BMS|Grant or research support-Elevation Oncology|Grant or research support-Genentech, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Merck|Grant or research support-Merus|Grant or research support-Nuvalent|Grant or research support-Pfizer, Inc.|Grant or research support-RAPT|Grant or research support-Turning Point Therapeutics
Faculty Photos
Eric D. Anderson, MD
Director, Interventional Pulmonology; Professor, Clinical Medicine; Pulmonary, Critical Care and Sleep Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC
Faculty
Honoraria-Intuitive Surgical
Faculty Photos
Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology, Professor, Department of Hematology/Oncology
The Gloria and Edmund M. Dunn Chair in Thoracic Oncology Fox Chase Cancer Center
Philadelphia, PA
Faculty
Grant or research support-BMS|Grant or research support-Lilly Oncology|Grant or research support-Amgen|Consulting Fee-BMS|Consulting Fee-Lilly Oncology|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Merck|Consulting Fee-EMD Serono|Consulting Fee-AstraZeneca AstraZeneca|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Genmab|Consulting Fee-Regeneron|Consulting Fee-Amgen|Consulting Fee-Takeda|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Janssen|Consulting Fee-Natera|Consulting Fee-Pharmamar|Consulting Fee-Beigene|Consulting Fee-Guardant|Consulting Fee-Oncocyte|Consulting Fee-Jazz|Consulting Fee-Da Volterra|Consulting Fee-iTEO|Consulting Fee-Mirati|Other: DSMB-Incyte|Other: DSMB-Takeda (Relationship has ended)|Other: DSMB-Novartis Pharmaceuticals|Other: DSMB-U of Penn|Stocks or stock options, excluding diversified mutual funds-Sonnetbio|Stocks or stock options, excluding diversified mutual funds-Inspirna|Stocks or stock options, excluding diversified mutual funds-Nucleai|Honoraria-Regeneron (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)|Honoraria-Amgen (Relationship has ended)|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended)
Faculty Photos
Ibiayi Dagogo-Jack, MD
Thoracic Oncologist, Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Consulting Fee-AstraZeneca AstraZeneca (Relationship has ended)|Consulting Fee-Bayer Corporation (Relationship has ended)|Consulting Fee-Janssen (Relationship has ended)|Consulting Fee-BMS (Relationship has ended)|Consulting Fee-Genentech, Inc. (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Grant or research support-Pfizer, Inc.|Consulting Fee-Sanofi (Relationship has ended)|Grant or research support-Array BioPharma (Relationship has ended)|Consulting Fee-Xcovery (Relationship has ended)|Consulting Fee-BostonGene (Relationship has ended)|Consulting Fee-Syros (Relationship has ended)|Consulting Fee-Novocure (Relationship has ended)
Faculty Photos
Narjust Florez, MD
Thoracic Medical oncologist, Associate Director, Cancer Care Equity Program, Member of the Faculty, Medicine
Dana-Farber Brigham Cancer Center, Harvard Medical School
Boston, MA
Faculty
Advisor-Astra Zeneca Astra Zeneca|Advisor-Novartis Pharmaceuticals|Advisor-Merck|Advisor-Pfizer, Inc.|Advisor-Janssen|Speakers Bureau-Neogenomics
Faculty Photos
Balazs Halmos, MD
Director, Thoracic/Head and Neck Oncology, Professor, Medicine
Montefiore Medical Center, Albert Einstein College of Medicine
Bronx, NY
Faculty
Consulting Fee-Boehringer Ingelheim|Consulting Fee-BMS|Consulting Fee-Merck|Grant or research support-AbbVie|Consulting Fee-Amgen|Consulting Fee-Astra Zeneca Astra Zeneca|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-GlaxoSmithKline|Consulting Fee-Janssen|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Takeda|Consulting Fee-Veracyte
Faculty Photos
Faysal Haroun, MD
Fellowship Program Director, Assistant Professor, Medicine, Division of Hematology & Oncology
The George Washington University School of Medicine and Health Sciences
Washington, DC
Faculty
Honoraria-Amgen
Faculty Photos
Puja G. Khaitan, MD
Director, Esophageal Surgery, Associate Professor, Thoracic Surgery
MedStar Washington Hospital Center, Georgetown University Medical Center
Washington, DC
Faculty
Nothing to disclose
Faculty Photos
Chul Kim, MD, MPH
Thoracic Medical Oncologist, Assistant Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC
Faculty
Consulting Fee-Novartis Pharmaceuticals (Relationship has ended)|Consulting Fee-Janssen (Relationship has ended)|Consulting Fee-PierianDx (Relationship has ended)|Consulting Fee-Astra Zeneca Astra Zeneca (Relationship has ended)|Consulting Fee-Sanofi (Relationship has ended)|Consulting Fee-Diffuse pharmaceuticals (Relationship has ended)|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Bristol-Myers Squib Aventis|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Regeneron|Grant or research support-Karyopharm|Grant or research support-Debiopharm|Grant or research support-Janssen|Grant or research support-Genentech, Inc.|Grant or research support-Spectrum|Grant or research support-Merck (Relationship has ended)
Faculty Photos
John F. Lazar, MD
Section Chief, Thoracic Robotics, Associate Professor, Thoracic Surgery
MedStar Washington Hospital Center, Georgetown University Medical Center
Washington, D.C.
Faculty
Nothing to disclose
Faculty Photos
Benjamin P. Levy, MD
Thoracic Medical Oncologist, Clinical Director, Medical Oncology; Associate Professor, Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Johns Hopkins University School of Medicine
Washington, DC
Faculty
Advisor-AstraZeneca AstraZeneca|Advisor-Pfizer, Inc.|Advisor-Janssen|Advisor-Amgen|Advisor-Genentech, Inc.|Advisor-Eli Lilly andCompany|Advisor-Takeda|Advisor-Gilead|Advisor-Daiichi Sankyo, Inc.|Advisor-Novartis Pharmaecuticals|Advisor-Sanofi
Faculty Photos
Jessica J. Lin, MD
Medical Oncologist, Attending Physician Center for Thoracic Cancers; Attending Physician, Henri and Belinda Termeer Center for Targeted Therapies; Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Paid consultant-Nuvalent|Paid consultant-Turning Point Therapeutics|Paid consultant-Bayer Corporation|Paid consultant-Mirati Therapeutics|Paid consultant-Blueprint Medicines (Relationship has ended)|Paid consultant-Elevation Oncology|Paid consultant-Genentech, Inc.|Paid consultant-Novartis Pharmaceuticals (Relationship has ended)|Paid consultant-Pfizer, Inc. (Relationship has ended)|Grant or research support-Hengrui Therapeutics|Grant or research support-Turning Point Therapeutics|Grant or research support-Neon Therapeutics|Grant or research support-Relay Therapeutics|Grant or research support-Bayer Corporation|Grant or research support-Elevation Oncology|Grant or research support-Roche|Grant or research support-Linnaeus Therapeutics|Grant or research support-Nuvalent|Grant or research support-Novartis Pharmaceuticals
Faculty Photos
Nitika Paudel, MD, PhD
Radiation Oncologist, Radiation Medicine; Assistant Professor, Radiation Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, DC
Faculty
Speakers Bureau-Astra Zeneca Astra Zeneca (Relationship has ended)
Faculty Photos
Zofia Piotrowska, MD, MHS
Medical Oncologist, Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Advisor-Astra Zeneca Astra Zeneca (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Consulting Fee-Eli Lilly andCompany (Relationship has ended)|Consulting Fee-Janssen (Relationship has ended)|Consulting Fee-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Takeda (Relationship has ended)|Advisor-Cullinan Oncology (Relationship has ended)|Advisor-C4 Therapeutics (Relationship has ended)|Advisor-Jazz Pharmaceuticals (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Takeda|Grant or research support-Spectrum|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Tesaro, Inc.|Grant or research support-Cullinan Oncology|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-AbbVie|Grant or research support-Janssen|Grant or research support-Blueprint Medicines
Faculty Photos
Joshua E. Reuss, MD
Thoracic Medical Oncologist; Assistant Professor, Medicine
MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Washington, DC
Faculty
Grant or research support-Genentech, Inc.|Paid consultant-Personalis|Honoraria-Astra Zeneca Astra Zeneca|Paid consultant-Guardant|Paid consultant-Sanofi|Grant or research support-verastem|Consulting Fee-Genentech, Inc. (Relationship has ended)|Honoraria-Oncocyte (Relationship has ended)
Faculty Photos
Christian D. Rolfo, MD
Professor and Associate Director for Clinical Research, Center for Thoracic Oncology
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System
New York, NY
Faculty
Consulting Fee-Inivata (Relationship has ended)|Consulting Fee-BMS (Relationship has ended)|Consulting Fee-Novartis Pharmaceuticals (Relationship has ended)|Speakers Bureau-Astra Zeneca Astra Zeneca|Speakers Bureau-Roche|Consulting Fee-Pfizer, Inc.|Consulting Fee-Eisai|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Sanofi|Consulting Fee-Bayer Corporation
Faculty Photos
Susan C. Scott, MD, MA
Thoracic Medical Oncologist, Assistant Professor, Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Johns Hopkins University School of Medicine
Washington, DC
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.
Faculty Photos
Brendon M. Stiles, MD
Associate Director, Surgical Services, Professor and Chief, Thoracic Surgery and Surgical Oncology
Montefiore-Einstein Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center
New York, NY
Faculty
Advisor-Astra Zeneca Astra Zeneca|Advisor-Genentech, Inc.|Advisor-Bristol-Myers Squib Aventis|Advisor-Pfizer, Inc.|Advisor-Medtronic, Inc.|Grant or research support-BMS
Janakiraman Subramanian , MD, MPH
Co-Director, Thoracic Oncology
Inova Schar Cancer Institute
Fairfax, VA
Faculty
Honoraria-Astra Zeneca Astra Zeneca|Advisor-Beigene (Relationship has ended)|Honoraria-Boehringer Ingelheim (Relationship has ended)|Advisor-Blueprint Medicines (Relationship has ended)|Advisor-Cardinal Health (Relationship has ended)|Advisor-Daiichi Sankyo, Inc.|Advisor-Eli Lilly andCompany|Honoraria-G1 therapeutics|Honoraria-Janssen|Honoraria-Jazz Pharma|Honoraria-Novartis Pharmaceuticals|Advisor-Oncocyte (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Takeda (Relationship has ended)
Faculty Photos
Irina G. Veytsman, MD
Section Director, Hematology/Oncology Medical Oncologist
MedStar Georgetown Cancer Institute, MedStar Washington Hospital Center
Washington, DC
Faculty
Nothing to disclose
Faculty Photos
Soo-Ryum (Stew) Yang, MD
Assistant Attending Pathologist, Thoracic and Diagnostic Molecular Pathology, Co-Director, Clinical Biomarker Development, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Brooklyn, NY
Faculty
Nothing to disclose
Faculty Photos
Jillian E. Thompson, ANP-BC, AOCNP
Nurse Practitioner
MedStar Georgetown University Hospital
Washington, DC
Faculty, Planner Content Reviewer
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals (Relationship has ended)
Marybeth V. Kazanas, PharmD
Senior Director, Clinical Pharmacy Services
MedStar Health
Ellicott City, MD
Faculty, Planning Committee Member
Nothing to disclose

Saturday, October 29, 2022

This conference includes continuing education on Smoking Cessation (0.25 CE credit)

Registration, Breakfast, and Visit the Exhibits
8:00AM - 8:30AM
Welcome and Introduction
8:30AM - 8:35AM
Stephen V. Liu, MD
Session I: Diagnosis
8:35AM - 9:50AM
Puja G. Khaitan, MD (Moderator)
Lung Cancer Screening
8:36AM - 8:50AM
Brendon M. Stiles, MD
Smoking Cessation
8:50AM - 9:05AM
Eric D. Anderson, MD
Biomarker testing for NSCLC
9:05AM - 9:20AM
Soo-Ryum (Stew) Yang, MD
Liquid Biopsy
9:20AM - 9:35AM
Christian D. Rolfo, MD (Speaker)
Questions and Discussion
9:35AM - 9:50AM
Eric D. Anderson, MD (Panelist)
Brendon M. Stiles, MD (Panelist)
Soo-Ryum (Stew) Yang, MD (Panelist)
Puja G. Khaitan, MD (Moderator)
Break and Visit the Exhibits
9:50AM - 10:05AM
Session II: Stage III Non-Small Cell Lung Cancer (NSCLC)
10:05AM - 11:45AM
John F. Lazar, MD (Moderator)
Proton Beam and Modern Radiation
10:06AM - 10:20AM
Nitika Paudel, MD, PhD
Minimally Invasive Surgical Techniques
10:20AM - 10:35AM
Puja G. Khaitan, MD
Perioperative Immunotherapy
10:35AM - 10:50AM
Joshua E. Reuss, MD
Perioperative Targeted Therapy
10:50AM - 11:05AM
Narjust Florez, MD
Immunotherapy in early-stage NSCLC Debate (Is There a Debate?) Neo-Adjuvant therapy
11:05AM - 11:15AM
Balazs Halmos, MD (Speaker)
DEBATE: Adjuvant IO for Stage IIIA
11:15AM - 11:25AM
Benjamin P. Levy, MD (Speaker)
Questions and Discussion
11:25AM - 11:45AM
Narjust Florez, MD (Panelist)
Nitika Paudel, MD, PhD (Panelist)
Joshua E. Reuss, MD (Panelist)
Puja G. Khaitan, MD (Panelist)
Balazs Halmos, MD (Panelist)
Benjamin P. Levy, MD (Panelist)
John F. Lazar, MD (Moderator)
Lunch and Visit the Exhibits
11:45AM - 12:15PM
Lunch Symposium Sponsored by Janssen Biotech, Inc.
12:15PM - 12:45PM

Please note this session is not eligible for CE Credits
Dessert and Visit the Exhibits
12:45PM - 1:15PM
Session III: Targeted Therapy for Advanced NSCLC
1:15PM - 3:05PM
Stephen V. Liu, MD (Moderator)
First-Line Therapy for Anaplastic Lymphoma Kinase + Non-Small Cell Lung Cancer (ALK+NSCLC)
1:16PM - 1:30PM
Susan C. Scott, MD, MA
Evolving Landscape of Treatment for Epidermal Growth Factor Receptor (EGFR) Mutant NSCLC
1:30PM - 1:45PM
Chul Kim, MD, MPH
Fusions: ROS1, RET, NTRK, NRG1
1:45PM - 2:00PM
Jessica J. Lin, MD
Treatment of KRAS Mutant NSCLC
2:00PM - 2:10PM
Irina G. Veytsman, MD
Targeted Therapies in NSCLC BRAF & MET
2:10PM - 2:20PM
Janakiraman Subramanian , MD, MPH
Antibody Drug Conjugates
2:20PM - 2:35PM
Benjamin P. Levy, MD
Acquired Resistance to Targeted Therapy
2:35PM - 2:50PM
Zofia Piotrowska, MD, MHS
Questions and Discussion
2:50PM - 3:05PM
Stephen V. Liu, MD (Moderator)
Chul Kim, MD, MPH (Panelist)
Jessica J. Lin, MD (Panelist)
Zofia Piotrowska, MD, MHS (Panelist)
Irina G. Veytsman, MD
Janakiraman Subramanian , MD, MPH (Panelist)
Break and Visit the Exhibits
3:05PM - 3:30PM
1L Immunotherapy in NSCLC
3:30PM - 3:45PM
Faysal Haroun, MD
Session IV: Immunotherapy for Advanced Thoracic Cancer
3:30PM - 5:00PM
Stephen V. Liu, MD (Moderator)
Chemotherapy Plus Immunotherapy in Metastatic NSCLC Without a Driver Mutation
3:45PM - 4:00PM
Hossein Borghaei, DO, MS
Small Cell Lung Cancer (SCLC)
4:00PM - 4:15PM
Stephen V. Liu, MD
Mesothelioma: Current Medical Management
4:15PM - 4:30PM
Ibiayi Dagogo-Jack, MD
IO Toxicities
4:30PM - 4:45PM
Jillian E. Thompson, ANP-BC, AOCNP
Questions and Discussion
4:45PM - 5:00PM
Stephen V. Liu, MD (Moderator)
Ibiayi Dagogo-Jack, MD (Panelist)
Faysal Haroun, MD (Panelist)
Jillian E. Thompson, ANP-BC, AOCNP (Panelist)
Hossein Borghaei, DO, MS (Panelist)
Closing Remarks
5:00PM - 5:05PM
Stephen V. Liu, MD

The D.C. Lung Cancer Conference is grateful to our educational grant supporters. They are listed below:

AstraZeneca Pharmaceuticals

Bristol Myers Squibb

Elevation Oncology, Inc.

Genentech, Inc. and Blueprint Medicines Corporation

Medical Device Business Services

If you are interested in supporting the program, please contact Elizabeth Romano at [email protected]


Thank you to our confirmed exhibitors!

Amgen Oncology

AstraZeneca

AstraZeneca Nurse Education

Biodesix

Blueprint Medicines

Bristol Myers Squibb

Caris Life Sciences

Genentech

Guardant Health

Janssen Biotech

Jazz Pharmaceuticals

Lilly Oncology

Merck

Natera

Novartis

Pfizer Inc.

Regeneron



Contact Us

MedStar Health, Department of Continuing Professional Education
[email protected]
CE.MedStarHealth.org